These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 29134565

  • 1. Prognostic value of FDG-PET and DWI in breast cancer.
    Kitajima K, Miyoshi Y, Yamano T, Odawara S, Higuchi T, Yamakado K.
    Ann Nucl Med; 2018 Jan; 32(1):44-53. PubMed ID: 29134565
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of 18F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging.
    Kitajima K, Yamano T, Miyoshi Y, Katsuura T, Enoki T, Yamakado K.
    Hell J Nucl Med; 2019 Jan; 22(1):25-35. PubMed ID: 30843007
    [Abstract] [Full Text] [Related]

  • 3. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
    Kitajima K, Yamano T, Fukushima K, Miyoshi Y, Hirota S, Kawanaka Y, Miya M, Doi H, Yamakado K, Hirota S.
    Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
    [Abstract] [Full Text] [Related]

  • 4. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.
    Qu YH, Long N, Ran C, Sun J.
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [Abstract] [Full Text] [Related]

  • 5. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E.
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH, Kang SM, Jeong SY, Lee SW, Lee SJ, Lee J, Ahn BC.
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [Abstract] [Full Text] [Related]

  • 7. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N, Kataoka M, Sugawara Y, Ochi T, Kiyoto S, Ohsumi S, Mochizuki T.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):738-46. PubMed ID: 24064322
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of metabolic tumour volume and total lesion glycolysis in 18F-FDG PET/CT scans in locally advanced breast cancer staging.
    Jiménez-Ballvé A, García García-Esquinas M, Salsidua-Arroyo O, Serrano-Palacio A, García-Sáenz JA, Ortega Candil A, Fuentes Ferrer ME, Rodríguez Rey C, Román-Santamaría JM, Moreno F, Carreras-Delgado JL.
    Rev Esp Med Nucl Imagen Mol; 2016 Nov 15; 35(6):365-372. PubMed ID: 26948652
    [Abstract] [Full Text] [Related]

  • 9. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B, Pourbagher A, Torun N.
    J Magn Reson Imaging; 2016 Jun 15; 43(6):1434-44. PubMed ID: 26663655
    [Abstract] [Full Text] [Related]

  • 10. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
    Yoo J, Kim BS, Chung J, Yoon HJ.
    Medicine (Baltimore); 2017 Aug 15; 96(31):e7657. PubMed ID: 28767583
    [Abstract] [Full Text] [Related]

  • 11. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer].
    Tang B, Zhang Y, Zhou J, Xu Y, Li TR, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2017 Apr 23; 39(4):280-285. PubMed ID: 28550668
    [Abstract] [Full Text] [Related]

  • 12. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.
    Medicine (Baltimore); 2016 May 23; 95(19):e3686. PubMed ID: 27175707
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY, Guo Z, Sun J, Yang WP, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ.
    Clin Nucl Med; 2017 May 23; 42(5):e235-e241. PubMed ID: 28288043
    [Abstract] [Full Text] [Related]

  • 15. Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
    Evangelista L, Cervino AR, Ghiotto C, Saibene T, Michieletto S, Fernando B, Orvieto E, Guarneri V, Conte P.
    Eur J Nucl Med Mol Imaging; 2015 Oct 23; 42(11):1648-1655. PubMed ID: 26025244
    [Abstract] [Full Text] [Related]

  • 16. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
    Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J.
    AJR Am J Roentgenol; 2015 Oct 23; 205(4):878-85. PubMed ID: 26204115
    [Abstract] [Full Text] [Related]

  • 17. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD.
    J Nucl Med; 2014 Jun 23; 55(6):898-904. PubMed ID: 24711649
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug 23; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 19. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.
    Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW.
    Eur J Nucl Med Mol Imaging; 2017 Oct 23; 44(11):1787-1795. PubMed ID: 28616695
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.
    J Gynecol Oncol; 2017 Jul 23; 28(4):e43. PubMed ID: 28541634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.